Cost-utility analysis of nonalcoholic steatohepatitis screening.
about
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesFormulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy.Liver fibrosis: Review of current imaging and MRI quantification techniques.Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.
P2860
Cost-utility analysis of nonalcoholic steatohepatitis screening.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@ast
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@en
type
label
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@ast
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@en
prefLabel
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@ast
Cost-utility analysis of nonalcoholic steatohepatitis screening.
@en
P2093
P2860
P1433
P1476
Cost-utility analysis of nonalcoholic steatohepatitis screening
@en
P2093
Claire Wartelle-Bladou
Eric Zhang
Guy Cloutier
Jean Lachaine
Luigi Lepanto
P2860
P2888
P304
P356
10.1007/S00330-015-3731-2
P407
P50
P577
2015-05-21T00:00:00Z